Litigation Details for FOREST LABORATORIES, LLC v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
✉ Email this page to a colleague
FOREST LABORATORIES, LLC v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-11-14 |
Court | District Court, D. New Jersey | Date Terminated | 2018-02-07 |
Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
Jury Demand | None | Referred To | Michael A. Hammer |
Patents | 8,481,598; 8,865,937; RE43,879 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FOREST LABORATORIES, LLC v. AUROBINDO PHARMA USA, INC.
Details for FOREST LABORATORIES, LLC v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-11-14 | 1 | United States Patent Nos. 8,481,598 (“the ’598 patent”), 8,865,937 (“the ’937 patent”), and RE43,879… infringed United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 by submitting ANDA… products before United States Patent Nos. 8,481,598 and RE43,879 expire, would …16 of 20 PageID: 16 States Patent Nos. 8,481,598, 8,865,937, and RE43,879, including any …. 210826 until United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 expire, including | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |